---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-133312"
form_type: "8-K/A"
ticker: null
cik: "0001808158"
company_name: "Repare Therapeutics Inc."
filed_at: "2025-06-02T23:59:59+00:00"
generated_at: "2026-05-20T03:09:29.432759+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Repare Therapeutics discloses employment terms for CAO Sandra Alves: CA$350k salary, 35% bonus target

## Summary
- Annual base salary: CA$350,000; target annual cash bonus: 35% of base salary.
- Non-change-in-control severance: 7 months' salary, benefits continuation, 6-month vesting acceleration.
- Change-in-control severance: lump sum of base salary plus higher of target or prior year bonus, 12 months benefits, full vesting.
- Employment agreement entered May 28, 2025, effective with Ms. Alves' appointment as CAO.
- Agreement will be filed with Q2 2025 Form 10-Q.

## SEC filing metadata
- accession: 0001193125-25-133312
- form_type: 8-K/A
- cik: 0001808158
- company_name: Repare Therapeutics Inc.
- filed_at: 2025-06-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808158/000119312525133312/0001193125-25-133312-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808158/000119312525133312/d925343d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-133312
- JSON: https://secwatch.observer/filing/0001193125-25-133312.json
- Plain text: https://secwatch.observer/filing/0001193125-25-133312.txt

## Key facts
- Executive change
  Sandra Alves was appointed as Senior Vice President, Chief Accounting Officer and principal accounting officer at Repare Therapeutics Inc..
  - Action: appointed
  - Role: Senior Vice President, Chief Accounting Officer and principal accounting officer
  source text: In connection with Ms. Alves’ appointment as the Company’s Senior Vice President, Chief Accounting Officer and principal accounting officer, the Company entered into an employment agreement with Ms. Alves on May 28, 2025 (the “ Employment Agreement ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808158/000119312525133312/0001193125-25-133312-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.